TELA TELA Bio Inc
Price (delayed)
$1.25
Market cap
$49.44M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.33
Enterprise value
$37.63M
TELA Bio Inc. is a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company is
Highlights
The quick ratio has soared by 136% since the previous quarter and by 21% year-on-year
The equity has surged by 51% year-on-year
The gross margin is down by 2.2% year-on-year
Key stats
What are the main financial stats of TELA
Market
Valuations
Earnings
Shares outstanding
39.55M
Market cap
$49.44M
Enterprise value
$37.63M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.73
Price to sales (P/S)
0.51
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.54
Revenue
$69.3M
Gross profit
$46.49M
Operating income
-$41.7M
Net income
-$37.84M
EBIT
-$32.7M
EBITDA
-$31.68M
Free cash flow
-$42.58M
Per share
Balance sheet
Liquidity
EPS
-$1.33
EPS diluted
-$1.33
Free cash flow per share
-$1.49
Book value per share
$0.72
Revenue per share
$2.43
TBVPS
$2.97
Total assets
$86.57M
Total liabilities
$58.11M
Debt
$41.12M
Equity
$28.46M
Working capital
$62.47M
Debt to equity
1.45
Current ratio
5.01
Quick ratio
4.04
Net debt/EBITDA
0.37
Margins
Efficiency
Dividend
EBITDA margin
-45.7%
Gross margin
67.1%
Net margin
-54.6%
Operating margin
-60.2%
Return on assets
-55.7%
Return on equity
-383.8%
Return on invested capital
-56.8%
Return on capital employed
-46.1%
Return on sales
-47.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TELA stock price
How has the TELA Bio stock price performed over time
Intraday
-1.57%
1 week
-3.1%
1 month
-48.98%
1 year
-76.42%
YTD
-58.61%
QTD
2.46%
Financial performance
How have TELA Bio's revenue and profit performed over time
Revenue
$69.3M
Gross profit
$46.49M
Operating income
-$41.7M
Net income
-$37.84M
Gross margin
67.1%
Net margin
-54.6%
TELA Bio's net margin has increased by 32% YoY and by 10% from the previous quarter
The operating margin has grown by 20% YoY and by 9% from the previous quarter
TELA's revenue is up by 19% year-on-year
The company's net income rose by 19% YoY and by 9% QoQ
Growth
What is TELA Bio's growth rate over time
Valuation
What is TELA Bio stock price valuation
P/E
N/A
P/B
1.73
P/S
0.51
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.54
TELA Bio's EPS has increased by 35% YoY and by 21% from the previous quarter
The P/B is 86% less than the 5-year quarterly average of 12.8
The equity has surged by 51% year-on-year
TELA's price to sales (P/S) is 91% less than its 5-year quarterly average of 5.6 and 65% less than its last 4 quarters average of 1.5
TELA's revenue is up by 19% year-on-year
Efficiency
How efficient is TELA Bio business performance
TELA Bio's return on equity has shrunk by 90% YoY but it has increased by 31% QoQ
TELA Bio's ROS has increased by 33% YoY and by 10% from the previous quarter
TELA's ROIC is up by 28% YoY and by 12% QoQ
TELA's ROA is up by 12% since the previous quarter and by 4.9% year-on-year
Dividends
What is TELA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TELA.
Financial health
How did TELA Bio financials performed over time
TELA's total assets is 49% more than its total liabilities
The quick ratio has soared by 136% since the previous quarter and by 21% year-on-year
The current ratio has soared by 91% from the previous quarter and by 18% YoY
TELA Bio's debt is 45% more than its equity
TELA Bio's debt to equity has surged by 122% QoQ but it has decreased by 33% YoY
The equity has surged by 51% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.